---
schema_version: "secwatch.filing_event.v1"
accession: "0001824293-24-000129"
form_type: "8-K"
ticker: "GRI"
cik: "0001824293"
company_name: "GRI Bio, Inc."
filed_at: "2024-09-06T23:59:59+00:00"
generated_at: "2026-05-31T06:06:31.952593+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# GRI Bio shareholders reject equity plan increase by 600K shares; director David Baker elected

## Summary
- David Baker elected Class I director with 61,134 for vs 40,091 against (155 abstain).
- Ratification of Sadler, Gibb & Associates as auditor passed: 285,641 for, 25,988 against.
- Proposal to issue shares underlying warrants (Nasdaq Rule 5635(d)) passed: 51,165 for, 47,971 against.
- Amendment to 2018 Equity Incentive Plan to add 600,000 shares failed: 31,556 for, 68,911 against.
- Quorum of 311,668 shares (42% of eligible) present at reconvened annual meeting.

## SEC filing metadata
- accession: 0001824293-24-000129
- form_type: 8-K
- ticker: GRI
- cik: 0001824293
- company_name: GRI Bio, Inc.
- filed_at: 2024-09-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000129/0001824293-24-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824293/000182429324000129/val-20240906.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001824293-24-000129
- JSON: https://secwatch.observer/filing/0001824293-24-000129.json
- Plain text: https://secwatch.observer/filing/0001824293-24-000129.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.